News | November 13, 2023
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
he company posted total income during Q2 FY24 at Rs. 12.86 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Apollo Telehealth has established more than 700 centers, in 7 states
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Need to harmonize traditional and modern medicine to combat alarming health problems
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Subscribe To Our Newsletter & Stay Updated
